SCHEMBL4631763

SCHEMBL4631763

CS(=O)(=O)OCCC1(c2ccc(F)c(F)c2)CN(Cc2cc(C(F)(F)F)cc(C(F)(F)F)c2)C(=O)CO1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.36
FPR1 P21462 1/20 0.36
GPR183 P32249 1/20 0.36
APLNR P35414 1/20 0.36
GLP1R P43220 1/20 0.36
GPBAR1 Q8TDU6 1/20 0.36
GPR35 Q9HC97 1/20 0.36
CYP2D6 P10635 2/20 0.35
CYP3A4 P08684 3/20 0.33
MEN1 O00255 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33
TSHR P16473 1/20 0.33
CYP2C19 P33261 1/20 0.33
KMT2A Q03164 1/20 0.33
TACR1 P25103 3/20 0.31
USP2 O75604 2/20 0.31
HPGD P15428 1/20 0.31
ALDH1A1 P00352 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4764844 0.90 TACR1 (0.35) ADRB2FPR1GPR183APLNRGLP1R
SCHEMBL4631764 0.88 CYP2D6 (0.36) ADRB2FPR1GPR183APLNRGLP1R
SCHEMBL4630779 0.88 TACR2 (0.34) TACR1
SCHEMBL7750393 0.85 ADRB2 (0.39) ADRB2FPR1GPR183APLNRGLP1R
SCHEMBL8483780 0.82 TACR1 (0.40) CYP2D6TACR1
SCHEMBL4630844 0.82 ADRB2 (0.37) ADRB2FPR1GPR183APLNRGLP1R
SCHEMBL4630898 0.78 TACR1 (0.44) TACR1
SCHEMBL4631237 0.77 CYP2D6 (0.36) CYP2D6CYP3A4MEN1CYP1A2CYP2C9
SCHEMBL4631148 0.76 TACR2 (0.46) CYP2D6CYP3A4MEN1CYP1A2CYP2C9
SCHEMBL4630854 0.76 TACR1 (0.41) TACR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1923391-A1 Substituted heterocyclic compounds, method for preparing same and pharmaceutical compositions containing them. sanofi-aventis (FR) 2008-05-21 EP disclosed
EP-1688416-A1 Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them Sanofi-Aventis (FR) 2006-08-09 EP disclosed
EP-1340754-A1 Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them SANOFI-SYNTHELABO (FR) 2003-09-03 EP disclosed
EP-1156049-A1 Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them SANOFI-SYNTHELABO (FR) 2001-11-21 EP disclosed
US-6242637-B1 USED IN TREATMENT INVOLVING THE TACHYKININ SYSTEM, SUCH AS PAIN, ALLERGY AND INFLAMMATION, CIRCULATORY, GASTROINTESTINAL, NEUROLOGICAL, AND NEUROPSYCHIATRIC DISORDERS SANOFI-SYNTHELABO (FR) 2001-06-05 US disclosed
US-6011154-A Substituted heterocyclic compounds, method of preparing them and pharmaceutical compositions in which they are present SANOFI (FR) 2000-01-04 US disclosed
US-5977359-A Substituted heterocyclic compounds, method of preparing them and pharmaceutical compositions in which they are present SANOFI (FR) 1999-11-02 US disclosed
US-5869663-A INTERMEDIATES FOR NEUROKININ RECEPTOR ANTAGONISTS SANOFI (FR) 1999-02-09 US disclosed
US-5780466-A DISORDERS ASSOCIATED WITH EXCESS TACHYKININS AND ALL NEUROKININ-DEPENDENT DISORDERS; ANALGESICS; RESPIRATORY, GASTROINTESTINAL, UROGENTIAL, IMMUNE, CARDIOVASCULAR AND CNS DISORDERS SANOFI (FR) 1998-07-14 US disclosed
EP-0807111-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME SANOFI (FR) 1997-11-19 EP disclosed
US-5641777-A NEUROKININ RECEPTOR ANTAGONIST SANOFI (FR) 1997-06-24 US disclosed
WO-1996023787-A1 SUBSTITUTED HETEROCYCLIC COMPOUNDS, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME SANOFI (FR) 1996-08-08 WO disclosed